Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study

References

• Glimelius B, Tiret E, Cervantes A, Arnold D. (2013). Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24:vi81–8.
   PubMed Web of Science ®Google Scholar
• Fokstuen T, Holm T, Glimelius B. (2009). Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer. Radiother Oncol 93:293–7.
   PubMed Web of Science ®Google Scholar
• Pettersson D, Glimelius B, Iversen H, et al. (2013). Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III trial. Br J Surg 100:969–75.
   PubMed Web of Science ®Google Scholar
• Ceelen W, Fierens K, Van Nieuwenhove Y, Pattyn P. (2009). Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer 124:2966–72.
   PubMed Web of Science ®Google Scholar
• Shin SJ, Yoon HI, Kim NK, et al. (2011). Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol 6:99.
   PubMed Web of Science ®Google Scholar
• Beppu N, Matsubara N, Kakuno A, et al. (2015). Feasibility of modified short-course radiotherapy combined with a chemoradiosensitizer for T3 rectal cancer. Dis Colon Rectum 58:479–87.
   PubMed Web of Science ®Google Scholar
• Kerr SF, Norton S, Glynne-Jones R. (2008). Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg 95:1534–40.
   PubMed Web of Science ®Google Scholar
• Jeong DH, Lee HB, Hur H, et al. (2013). Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Korean Surg Soc 84:338–45.
   PubMedGoogle Scholar
• Barsukov Iu A, Tkachev SI, Oltarzhevskaia ND, et al. (2008). [Combined treatment for rectal cancer using different radiomodification means]. Vopr Onkol 54:350–3.
   PubMedGoogle Scholar
• Barsukov YA, Gordeyev SS, Tkachev SI, et al. (2013). Phase II study of concomitant chemoradiotherapy with local hyperthermia and metronidazole for locally advanced fixed rectal cancer. Colorectal Dis 15:1107–14.
   PubMed Web of Science ®Google Scholar
• Kang MK, Kim MS, Kim JH. (2011). Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Hyperthermia 27:482–90.
   PubMed Web of Science ®Google Scholar
• Yeo SG, Oh JH, Kim DY, et al. (2013). Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01). Int J Radiat Oncol Biol Phys 86:34–9.
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. (2006). Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–23.
   PubMed Web of Science ®Google Scholar
• Gerard JP, Conroy T, Bonnetain F, et al. (2006). Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–5.
   PubMed Web of Science ®Google Scholar
• Pettersson D, Holm T, Iversen H, et al. (2012). Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 99:577–83.
   PubMed Web of Science ®Google Scholar
• Overgaard J. (2007). Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25:4066–74.
   PubMed Web of Science ®Google Scholar
• Wasserberg N. (2014). Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol 20:4256–62.
   PubMed Web of Science ®Google Scholar
• Evans J, Tait D, Swift I, et al. (2011). Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Dis Colon Rectum 54:1251–9.
   PubMed Web of Science ®Google Scholar
• Sloothaak DA, Geijsen DE, van Leersum NJ, et al. (2013). Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg 100:933–9.
   PubMed Web of Science ®Google Scholar
• Petrelli F, Sgroi G, Sarti E, Barni S. (2013). Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies. Ann Surg 263:458–64.
   PubMed Web of Science ®Google Scholar
• Beppu N, Matsubara N, Noda M, et al. (2014). The timing of surgery after preoperative short-course S-1 chemoradiotherapy with delayed surgery for T3 lower rectal cancer. Int J Colorectal Dis 29:1459–66.
   PubMed Web of Science ®Google Scholar
• Pettersson D, Lorinc E, Holm T, et al. (2015). Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg 102:972–8.
   PubMed Web of Science ®Google Scholar
• Faria S, Kopek N, Hijal T, et al. (2014). Phase II trial of short-course radiotherapy followed by delayed surgery for locoregionally advanced rectal cancer. Colorectal Dis 16:O66–70.
   PubMed Web of Science ®Google Scholar
• Sirohi B, Barreto SG, Patkar S, et al. (2014). Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: does timing of surgery really matter? Indian J Med Paediatr Oncol 35:263–6.
   PubMedGoogle Scholar
• Aschele C, Cionini L, Lonardi S, et al. (2011). Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 29:2773–80.
   PubMed Web of Science ®Google Scholar
• O'Connell MJ, Colangelo LH, Beart RW, et al. (2014). Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04. J Clin Oncol 32:1927–34.
   PubMed Web of Science ®Google Scholar
• De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, et al. (2009). Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev (3):CD006269.
   PubMed Web of Science ®Google Scholar
• Shoji H, Motegi M, Osawa K, et al. (2015). A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study. Cancer Med 4:834–43.
   PubMed Web of Science ®Google Scholar
• Ngan SY, Burmeister B, Fisher RJ, et al. (2012). Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with t3 rectal cancer: trans-tasman radiation oncology group trial 01.04. J Clin Oncol 30:3827–33.
   PubMed Web of Science ®Google Scholar
• van Gijn W, Marijnen CA, Nagtegaal ID, et al. (2011). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–82.
   PubMed Web of Science ®Google Scholar